Hörl W H
Department of Internal Medicine, University of Homburg/Saar, Germany.
Biotechnol Ther. 1991;2(3-4):213-30.
A deficiency of erythropoietin is the major cause of anemia in patients with chronic renal failure. In 1984 Eschbach and co-workers (1) demonstrated that daily injections of erythropoietin-rich plasma corrected anemia in chronically uremic sheep. In the first studies of r-huEPO given to severely anemic hemodialysis patients, all patients showed increments of their reticulocyte counts and hemoglobin concentrations. The need for further blood transfusions was eliminated and hematocrits were restored to normal (2,3).
促红细胞生成素缺乏是慢性肾衰竭患者贫血的主要原因。1984年,埃施巴赫及其同事(1)证明,每日注射富含促红细胞生成素的血浆可纠正慢性尿毒症绵羊的贫血。在首次对重度贫血血液透析患者使用重组人促红细胞生成素的研究中,所有患者的网织红细胞计数和血红蛋白浓度均有所增加。不再需要进一步输血,血细胞比容恢复正常(2,3)。